| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Dawes Karen A is a Director at REPLIGEN CORP with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 28 sells.
Estimated insider holdings value: $11.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | RGEN Repligen Corp | Director | Sell | 4,585 | $202.09 | $926,604.97 | -1.0% | +30.0% | -12.9% | |
| Jul 13, 2021 | RGEN Repligen Corp | Director | Sale+OE | 1,520 | $202.23 | $307,389.60 | -1.3% | +26.3% | -17.5% | |
| May 11, 2021 | RGEN Repligen Corp | Director | Sale+OE | 285 | $176.85 | $50,402.25 | -0.2% | +45.6% | -19.1% | |
| May 4, 2021 | BRNS Barinthus Biotherapeutics Plc. | Director | Buy | 1,700 | $17.00 | $28,900.00 | New | +14.1% | -62.1% | |
| Jun 18, 2020 | RGEN Repligen Corp | Director | Sell | 18,705 | $115.20 | $2,154,850.73 | -4.1% | - | - | |
| May 20, 2020 | RGEN Repligen Corp | Director | Sell | 517 | $139.44 | $72,092.82 | -0.1% | - | - | |
| May 18, 2020 | RGEN Repligen Corp | Director | Sell | 1,600 | $137.78 | $220,448.01 | -0.2% | - | - | |
| Apr 20, 2020 | RGEN Repligen Corp | Director | Sale+OE | 12,200 | $104.57 | $1,275,717.12 | -5.1% | - | - | |
| Feb 21, 2020 | RGEN Repligen Corp | Director | Sell | 4,000 | $98.70 | $394,793.45 | -0.9% | - | - | |
| Jun 17, 2019 | RGEN Repligen Corp | Director | Sale+OE | 1,295 | $77.35 | $100,168.25 | -1.1% | - | - |